Our Pricing

Mounjaro vs Ozempic: Clinical Comparison and UK Pricing

When comparing mounjaro vs ozempic uk price and efficacy, UK patients need clear, evidence-based guidance from registered pharmacy professionals. At Cured Pharmacy, our clinical team has supported thousands of patients through GLP-1 weight loss treatments, and we've compiled this comprehensive comparison to help you make an informed decision with transparent pricing from £135.00.

Mounjaro vs Ozempic: How They Work Differently

Mounjaro (tirzepatide) and Ozempic (semaglutide) both belong to the incretin-based therapy class, but they activate different receptor pathways in your body. Mounjaro is the UK's first dual GIP/GLP-1 receptor agonist, meaning it activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously [1]. This dual action enhances insulin secretion, suppresses glucagon release, and significantly reduces appetite through central nervous system pathways.

Ozempic, by contrast, is a selective GLP-1 receptor agonist that works through a single pathway [2]. While highly effective for blood sugar control and weight management, it lacks the additional GIP receptor activation that contributes to Mounjaro's enhanced metabolic effects. Both medications slow gastric emptying and increase satiety, but clinical trial data suggests the dual mechanism produces greater average weight reduction over comparable timeframes [1][3].

From a prescribing perspective, our superintendent pharmacist Tarun Kumar (GPhC 2233073) notes that patients often tolerate the dual-action mechanism well once they've titrated through the initial dosing schedule. Both treatments require subcutaneous injection once weekly, and both are licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities.

Clinical Trial Data: Mounjaro vs Ozempic Weight Loss Results

The SURPASS clinical trial programme evaluated tirzepatide across multiple doses and patient populations. In SURPASS-3, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks, with some individuals losing up to 25% of their baseline weight [1]. The 10mg dose produced an average 19.5% reduction, whilst the 5mg starting dose showed approximately 15% average weight loss.

Comparative data from the STEP trials examining semaglutide (the active ingredient in Ozempic and Wegovy) demonstrated an average weight reduction of 14.9% over 68 weeks at the 2.4mg dose [2]. The lower 1mg dose typically prescribed for type 2 diabetes management produces more modest weight loss averaging 6-7%. These results, whilst clinically significant, fall below the average reductions observed with tirzepatide in head-to-head analyses [3].

It's crucial to emphasise that these are average trial results, and individual responses vary considerably based on adherence, lifestyle modifications, baseline metabolic health, and genetic factors. During your free consultation at Cured Pharmacy, our UK prescribers assess your medical history, current medications, and weight loss goals to determine which treatment may be most appropriate for your circumstances.

Real-World Effectiveness Beyond Clinical Trials

Clinical trials are conducted under controlled conditions with high adherence monitoring, so real-world effectiveness can differ. UK registry data and post-marketing surveillance suggest that patients who combine GLP-1 therapy with structured dietary changes and regular physical activity achieve results closer to trial averages. Those who rely on medication alone without lifestyle modification typically see more modest outcomes, regardless of which treatment they're prescribed.

Side Effects: What to Expect With Each Treatment

Both Mounjaro and Ozempic share a similar side effect profile, as you'd expect from medications working on overlapping pathways. The most commonly reported adverse effects are gastrointestinal: nausea, diarrhoea, constipation, vomiting, and abdominal discomfort [1][2]. These symptoms typically emerge during dose escalation and often diminish after 4-8 weeks as your body adapts to the medication.

In the SURPASS trials, approximately 20-30% of tirzepatide patients reported nausea, with rates varying by dose. Discontinuation due to gastrointestinal side effects occurred in roughly 6-8% of participants [1]. Semaglutide trials showed comparable rates, with nausea affecting 20-44% of participants depending on the dose, and discontinuation rates of 4-7% [2]. Our clinical team at Cured Pharmacy advises patients to eat smaller, more frequent meals and avoid high-fat foods during the initial titration period to minimise these effects.

Less common but more serious potential side effects include pancreatitis, gallbladder disease, acute kidney injury, and hypoglycaemia (particularly when combined with insulin or sulphonylureas). Both medications carry a boxed warning in their prescribing information regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [4]. Your UK prescriber will review your personal and family medical history during consultation to ensure these treatments are safe for you.

Managing Side Effects Effectively

If you experience persistent nausea or vomiting that prevents adequate fluid intake, contact your prescriber immediately. Our clinical team is available on (+44) 116 4646009 during business hours for medication queries. Simple strategies like taking your injection on a full stomach, staying well-hydrated, and avoiding alcohol can significantly reduce gastrointestinal symptoms. Never increase your dose faster than prescribed, as this substantially increases side effect risk.

Dosing Schedules and Treatment Duration

Mounjaro follows a structured dose escalation protocol starting at 2.5mg once weekly for the first four weeks. This initial dose is sub-therapeutic and serves primarily to improve gastrointestinal tolerance. At week five, the dose increases to 5mg, which represents the minimum therapeutic dose for weight management. Most patients then titrate to 10mg or 15mg based on efficacy and tolerability, with dose increases occurring at four-week intervals [1].

Ozempic typically starts at 0.25mg once weekly for four weeks, increasing to 0.5mg for at least four weeks before considering further escalation to 1mg. For weight management specifically, higher doses up to 2mg may be prescribed, though this is less commonly available in standard Ozempic presentations compared to the Wegovy formulation [2]. The slower titration schedule helps your body adapt to the medication's effects on gastric emptying and appetite regulation.

Both treatments are intended for long-term use rather than short-term weight loss courses. Clinical trials extended beyond 72 weeks, and discontinuation typically results in gradual weight regain for most patients. NICE guidance emphasises that these medications should be prescribed alongside comprehensive lifestyle intervention programmes, and treatment should be reviewed regularly to assess ongoing benefit and tolerability.

Mounjaro vs Ozempic UK Price Comparison at Cured Pharmacy

At Cured Pharmacy, Mounjaro pricing starts from £135.00 per month, making it one of the most competitively priced options available through UK-registered online pharmacies. This transparent pricing includes your medication, free clinical consultation with a UK prescriber, and discreet home delivery. Unlike some services, we display prices upfront before you complete your medical assessment, so there are no unexpected costs at checkout.

We also stock alternative GLP-1 treatments at various price points to suit different budgets and clinical needs. Our pricing structure reflects our commitment to making evidence-based weight loss treatments accessible to more UK patients whilst maintaining the highest standards of pharmaceutical care and regulatory compliance. All prescriptions are dispensed from our GPhC-registered pharmacy (registration number 9012511) and reviewed by our superintendent pharmacist.

When comparing costs across the UK market, it's important to consider what's included in the quoted price. Some providers advertise lower headline figures but add consultation fees, delivery charges, or mandatory subscription commitments. At Cured Pharmacy, the price you see includes everything except any dose adjustments your prescriber recommends during follow-up reviews. We also offer a lowest price guarantee—if you find genuine UK-licensed Mounjaro cheaper elsewhere with equivalent service standards, we'll match it.

Understanding Long-Term Treatment Costs

Weight management with GLP-1 medications represents a long-term investment in your health. Most patients continue treatment for at least 12-18 months to achieve and maintain their target weight loss. When budgeting for treatment, factor in the full duration rather than just the initial months. Our clinical team can discuss treatment timelines during your consultation and help you understand the expected commitment before you begin.

Which Treatment Is Right for You? Clinical Considerations

Choosing between Mounjaro and Ozempic depends on multiple factors beyond just efficacy data. Your current health status, medication history, weight loss goals, budget, and personal preferences all influence which treatment your UK prescriber may recommend. Patients with type 2 diabetes may benefit from either medication, as both improve glycaemic control alongside weight reduction [1][2].

If you've previously tried single-pathway GLP-1 treatments with suboptimal results, the dual-action mechanism of Mounjaro may offer enhanced efficacy. Conversely, if you're particularly sensitive to gastrointestinal side effects, starting with a lower-dose option and titrating very gradually might be more appropriate. Some patients find the injection experience differs slightly between devices, though both use pre-filled pens designed for ease of use.

During your free online consultation at Cured Pharmacy, you'll complete a comprehensive medical questionnaire that our UK prescribers review in detail. This assessment covers your weight history, previous weight loss attempts, current medications, cardiovascular health, kidney function, and any contraindications to GLP-1 therapy. Based on this information, your prescriber will recommend the most suitable treatment option and discuss realistic expectations for your individual circumstances. The consultation typically takes under three minutes to complete, and most patients receive a prescribing decision within 24 hours.

When to Consider Alternative Treatments

Not everyone is a suitable candidate for Mounjaro or Ozempic. Patients with a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or previous pancreatitis may require alternative approaches. We stock a comprehensive range of weight loss treatments including Wegovy, Saxenda, Orlistat, and Xenical to ensure we can offer appropriate options for diverse patient needs. Your prescriber will guide you to the safest and most effective choice for your situation.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
3. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
4. Medicines and Healthcare products Regulatory Agency. (2023). Glucagon-like peptide-1 (GLP-1) receptor agonists: reports of thyroid cancer. Drug Safety Update, 16(9). https://www.gov.uk/drug-safety-update

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro and Ozempic are prescription-only medicines that may not be suitable for everyone. Individual results vary, and weight loss outcomes depend on adherence to treatment and lifestyle modifications.